KLRK1 and exocrine pancreatic carcinoma: Altogether, this study indicated that knockdown of 4.1R could activate NKG2D-CAR T cells and increase the release of INF-γ and Gzm B via ERK signaling pathway, thereby, enhancing the anti-tumor activity of NKG2D-CAR T cells against pancreatic carcinoma.